Maresin - OmicsDI

Show results for

Unknown (102)
Genomics (13)
Transcriptomics (11)
Proteomics (3)
Metabolomics (2)

Organisms

Mus musculus (9)
Homo sapiens (2)
Schizophyllum commune H4-8 (2)
Mycobacterium tuberculosis SP7 (2)
Oryza sativa Japonica Group (2)
Candidatus Endoriftia persephonae (2)
Mycobacterium tuberculosis SP10 (2)
Mycobacterium tuberculosis SP13 (2)
Mycobacterium tuberculosis SP22 (2)
Enterobacter ludwigii (2)
Chlamydomonas reinhardtii (2)
Lama (2)
Pyricularia oryzae P131 (2)
Enterococcus mundtii CRL35 (2)
Oncorhynchus tshawytscha (2)
Pseudomonas canadensis (2)
Strongylocentrotus purpuratus (2)
Influenza A virus (A/California/04/2009(H1N1)) (2)
Homo (2)
Pseudomonas aeruginosa PAO1H2O (2)
Human alphaherpesvirus 1 strain 17 (2)
Quercus petraea (2)
Canis lupus (2)
Mycobacterium tuberculosis SP1 (2)
Marchantia polymorpha subsp. ruderalis (2)
Zymomonas mobilis subsp. mobilis ZM4 = ATCC 31821 (2)
Curtobacterium pusillum (2)
Methylocystis sp. (2)
Exiguobacterium sp. SH31 (2)
Rattus norvegicus (1)

Organisms

Mus musculus (11)
Rattus norvegicus (1)

Repository

ENA (13)
geo (10)
pride (2)
biostudies-arrayexpress (1)
iProX (1)
MetaboLights (1)
MetabolomicsWorkbench (1)

Tissue

Epithelial cells (1)
Macrophage (1)
Stem cell (1)
Blood (1)
Cell culture (1)

Disease

Lung disease (1)
Periodontitis (1)
Disease free (1)

Technology Type

Mass Spectrometry (3)
Shotgun proteomics (2)
Mass spectrometry assay (1)
ESI (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2024 (4)
2026 (2)
2025 (2)
2023 (2)
2013 (1)
2022 (1)
2019 (1)
2018 (1)
2021 (1)

Metabolite Name

6-({2-[3,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]propanoyl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
8-hydroxy-7-methoxy-6-(3-oxobutyl)-2H-chromen-2-one (1)
[2-hydroxy-5-(3-oxobutyl)phenyl]oxidanesulfonic acid (1)
({4-[4,6-dihydroxy-3-(6-hydroxy-3-oxo-2,3-dihydro-1-benzofuran-2-yl)-2-methoxyphenyl]-2-methylbut-2-en-1-yl}oxy)sulfonic acid (1)
4-(3,7-dimethyloct2,6-dien-1-yl)benzene-1,2,3,5-tetrol (1)
[3-(2-methyl-3-oxopropyl)phenyl]oxidanesulfonic acid (1)
{3-hydroxy-5-oxo-2-[3-(sulfooxy)phenyl]-5H-chromen-7-yl}oxidanium (1)
17-U-46619 (1)
Lactucain B (1)
3,6-anhydro-L-galactonic acid (1)
3-[(2Z,5R)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate (1)
(2R,5R,6R)-6-hydroxy-2,6,8,9-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-1-oxaspiro[4.5]dec-8-ene-7,10-dione (1)
(24S)-3alpha,7alpha,12alpha,24-tetrahydroxy-5betcholestan-26-oate (1)
(6aR,9R,10aR)-9-(methylsulfinylmethyl)-7-propyl-6,6a,8,9,10,10hexahydro-4H-indolo[4,3-fg]quinoline (1)
Hydrogen isocitrate (1)
(2E)-3-chloro-2-hydroxypent2,4-dienoic acid (1)
11,12-Epoxy-5,8,14-eicosatrienoic acid (1)
Arogenic acid (1)
(2S)-2-amino-5-iminopentanoate (1)
3-(cis-5,6-Dihydroxycyclohex1,3-dien-1-yl)propanoate (1)
Protoporphyrinogen (1)
6-[(10-Butanoyl-3-hydroxy-2,2-dimethyl-8-oxo-6-propyl-3,4-dihydropyrano[3,2-g]chromen-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
6alphHydroxycastasterone (1)
(2S,3R,4R,5S)-2-[(3R,5S,8R,9S,10S,13S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5,6-dimethylheptane-3,4-diol (1)
4,4'-Diselenobis[(S)-2-aminobutanoic acid] (1)
Dimethylmaleic acid (1)
(Z)-3-aminoperacrylic acid (1)
9-Oxo-11alpha,16R-dihydroxy-17-cyclobutyl-prost-13E-en-1-oic acid (1)
[5,7-Dihydroxy-2-(3-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl] hydrogen sulate (1)
(2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltridec2,6-dienoic acid (1)

First Public Date

2025 (3)
2024 (3)
2017 (2)
2026 (1)
2022 (1)
2020 (1)
2019 (1)
2018 (1)

Study type

Transcription profiling by RT-PCR (1)

Release Date

2023 (13)
2021 (13)
2022 (12)
2020 (10)
2025 (9)
2024 (8)
2019 (8)
2018 (7)
2016 (7)
2015 (7)
2013 (3)
2012 (3)
2017 (2)
2014 (1)

Lab affiliation

Centre for Genomics and Computational Biology Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ (1)
The Forsyth Institute (1)

Previous page
1 / 14
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 14
Next page

Sort by:

Relevance

Page size

Gene expression profiles of maresin 1-treated Kupffer cells

PRJNA505180 | ENA

Maresin-1 and Resolvin E1 promote regenerative properties of periodontal ligament stem cells under inflammatory conditions

Maresin-1 (MaR1) and Resolvin E1 (RvE1) are specialized pro-resolving lipid mediators (SPMs) that regulate inflammatory processes. We have previously demonstrated the hard and soft tissue regenerative capacity of RvE1 in an in vivo model of periodontal disease characterized by inflammatory tissue de...

ORGANISM(S): Homo sapiens (Human)

2021-09-09 | PXD019546 | Pride

Gene expression profiles of maresin 1-treated Kupffer cells

To reveal the transcriptomes associated with Maresin 1-treated Kupffer cells, the primary Kupffer cells isolated from mouse liver were treated with maresin 1 and the gene expression patterns were analyzed by microarray.

ORGANISM(S): Mus musculus

2019-04-03 | GSE122430 | GEO

Maresin 1 Repletion Improves Muscle Regeneration After Volumetric Muscle Loss

PRJNA890648 | ENA

Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders

PRJNA475007 | ENA

Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders

Maresin 1 administered to mice prior to orthopedic surgery exerts distinct anti-inflammatory and pro-resolving effects through regulation of MΦ infiltration, NF-κB signaling, and cytokine release. We used microarrays to detail the global programme of gene expression underlying Maresin 1 effect on mo...

ORGANISM(S): Mus musculus

2018-11-13 | GSE115440 | GEO

Maresin-1 impairs cutaneous wound healing response.

Not available

S-EPMC11964490 | biostudies-literature

Maresin 1 Modulates Cardiac and Renal Lipid Profiles in Hypertensive Rats

PRJNA1247525 | ENA

Stereoselective Synthesis of Maresin-like Lipid Mediators.

Not available

S-EPMC6510270 | biostudies-literature

Maresin 1 Repletion Improves Muscle Regeneration After Volumetric Muscle Loss

The acute traumatic or surgical loss of skeletal muscle, known as volumetric muscle loss (VML), is a devastating type of injury that results in exacerbated and persistent inflammation followed by fibrosis. The mechanisms that mediate the magnitude and duration of the inflammatory response and ensuin...

ORGANISM(S): Mus musculus

2024-01-18 | GSE215808 | GEO

Previous page
1 / 14
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 14
Next page

Sort by:

Relevance

Page size

131 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets